William L. Pridgen
2020
In 2020, William L. Pridgen earned a total compensation of $2.4M as Founder and Chief Executive Officer at Virios Therapeutics, a 593% increase compared to previous year.
Compensation breakdown
| Salary | $87,500 |
|---|---|
| Stock Awards | $2,336,880 |
| Total | $2,424,380 |
Pridgen received $2.3M in stock awards, accounting for 96% of the total pay in 2020.
Pridgen also received $87.5K in salary.
Rankings
In 2020, William L. Pridgen's compensation ranked 4,699th out of 13,090 executives tracked by ExecPay. In other words, Pridgen earned more than 64.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,699 out of 13,090 | 64th |
Division Manufacturing | 1,909 out of 5,618 | 66th |
Major group Chemicals And Allied Products | 748 out of 2,251 | 67th |
Industry group Drugs | 642 out of 1,951 | 67th |
Industry Pharmaceutical Preparations | 486 out of 1,456 | 67th |
Source: SEC filing on April 28, 2021.
Pridgen's colleagues
We found five more compensation records of executives who worked with William L. Pridgen at Virios Therapeutics in 2020.
2020
Greg Duncan
Virios Therapeutics
Chief Executive Officer
2020
Richard Burch
Virios Therapeutics
President
2020
Angela Walsh
Virios Therapeutics
Vice President of Finance
2020
Ralph Grosswald
Virios Therapeutics
Vice President of Operations
2020
R Gendreau
Virios Therapeutics